ENALAPRIL (has an active metabolite) | ENALAPRIL | ATC C09AA02 ATC C09BA02 ATC C09BB02 ATC C09BB06
CARDIOVASCULAR ANTIHYPERTENSIVE ANGIOTENSIN-CONVERTING ENZYME INHIBITORS | ORAL | F 60 PERCENT | ANGIOTENSIN-CONVERTING ENZYME | ANGIOTENSIN-CONVERTING ENZYME INHIBITOR CHEMBL1808 ANGIOTENSIN-CONVERTING ENZYME P12821 ANGIOTENSIN-CONVERTING ENZYME HOMO SAPIENS ENZYME PROTEASE METALLO MAE M2 | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |
ENALAPRILAT (is an active metabolite) | ENALAPRILAT | ATC C09AA02
CARDIOVASCULAR ANTIHYPERTENSIVE ANGIOTENSIN-CONVERTING ENZYME INHIBITORS | INJECTION | VD 24.7 LITER (65 KILOGRAM) PPB 38 PERCENT Cl 6.2 LITER / HOUR (65 KILOGRAM) HT 11 HOUR SOLUBILITY SPARINGLY SOLUBLE IN WATER | ANGIOTENSIN-CONVERTING ENZYME (ACE) PDB 1UZE (COMPLEX OF THE ANTI-HYPERTENSIVE DRUG ENALAPRILAT AND THE HUMAN TESTICULAR ANGIOTENSIN I-CONVERTING ENZYME) LIGAND CODE = EAL (link to the list of PDB complexes) Download experimental 3D coordinates of EAL with added hydrogens | ANGIOTENSIN-CONVERTING ENZYME INHIBITOR CHEMBL1808 ANGIOTENSIN-CONVERTING ENZYME P12821 ANGIOTENSIN-CONVERTING ENZYME HOMO SAPIENS ENZYME PROTEASE METALLO MAE M2 | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |